Evkeeza
These highlights do not include all the information needed to use EVKEEZA safely and effectively. See full prescribing information for EVKEEZA. EVKEEZA (evinacumab-dgnb) injection, for intravenous use Initial U.S. Approval: 2021
73412138-6d8f-4ea6-bb72-a740190470ff
HUMAN PRESCRIPTION DRUG LABEL
Mar 30, 2023
Regeneron Pharmaceuticals, Inc.
DUNS: 194873139
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
evinacumab
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
evinacumab
Product Details
FDA regulatory identification and product classification information